Skip to content
Search

Latest Stories

NHS England chair Richard Meddings resigns amid strategic healthcare shifts

NHS England chair Richard Meddings resigns amid strategic healthcare shifts

Post his resignation, Richard Meddings will continue to contribute in the creation of the 10-Year Health Plan, which he describes as “a significant opportunity to change the NHS”

Richard Meddings, the Chair of NHS England, has announced his decision to step down from his position at the end of March 2025.


Meddings, who has served in this role for nearly three years, described the decision as “a very difficult one,” but he believes it is the right time to resign and has notified Health Secretary Wes Streeting.

In a message to NHS England staff, Meddings stated: “As I approach the end of my first three-year term in the role, and having had discussions with the health secretary about what the NHS and social care will need over the next decade, I have decided that now is the right time for me to step down as chair.

“This has been a very difficult decision. The role of NHS England chair has been one of the most personally satisfying, demanding and challenging positions I’ve ever had.”

Despite his resignation, Meddings will continue to contribute to the development of the 10-year health plan over the coming months.

“I am clear that the plan is a significant opportunity to change the NHS, and the shifts set out by the government – to prevention, to primary and community care, and to digital – are the right long-term goals,” he said.

Streeting expressed his gratitude to Richard for the support he has provided to him and the ministerial team during their first months in office.

He said: “Richard has led the organisation through a period of significant internal change and unprecedented external challenges and has done so with the greatest dedication and integrity. From all of our conversations his commitment to the role has been evident.

“Those who have benefited from his leadership and stewardship of NHS England speak with warmth, affection and gratitude. I also want to say a personal thank you to Richard for the support he has given me and the ministerial team during our first months in office.”

Before joining the NHS, Meddings had a successful career spanning over 30 years in banking and financial services, including seven years on the HM Treasury board.

NHS chief executive Amanda Pritchard also expressed her appreciation for Meddings’ dedication to the NHS and his efforts in driving improvements and efficiencies within their services.

“He has been incredibly passionate about identifying, implementing and championing the solutions to the challenges that will help us to make the NHS fit for the future – from embracing the latest tech and innovations including the NHS App, genomic medicine and cancer vaccines to new models of care.

“I am personally grateful for the unwavering support he has given to me and our executive team as we have navigated what has been one of the most difficult periods for the NHS, for our staff and for our patients,” she said.

The Department of Health and Social Care plans to advertise the Chair position soon, allowing an open and competitive selection process, along with the necessary parliamentary approvals.

 

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less